Cyclomedica Usa, LLC

Cyclomedica USA, LLC, a foreign-owned for-profit medical technology company based in Tucker, Georgia, supplies specialized diagnostic equipment and pharmaceutical products for nuclear medicine to the federal healthcare system exclusively as a prime contractor, competing without small business set-asides in a niche market anchored by sole-source awards.

Cyclomedica's federal capability centers on Technegas and Technegas Plus diagnostic systems—specialized equipment used for pulmonary and ventilation studies to detect pulmonary embolism and respiratory diseases—and related pharmaceutical kits for preparation of Technetium used in nuclear medicine procedures. The company operates under primary NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 532490 (Other Commercial and Industrial Machinery and Equipment Rental and Leasing), with PSC concentration in Drugs and Biologicals (5 awards) and Medical Equipment Lease or Rental (4 awards). Representative recent work includes a $50.55 million delivery order from Veterans Integrated Service Network 7 for lease of medical equipment and nuclear medicine supplies through March 2031, a $200.2 million firm fixed-price purchase order from the Defense Health Agency for Technetium kits awarded October 2024, a $81.67 million lease and service agreement from Veterans Integrated Service Network 21 for Technegas Plus equipment through September 2029, and multiple smaller purchase orders from Veterans Integrated Service Network 17 and the NIH Clinical Center ranging from $9.75 thousand to $50.55 thousand.

Customer concentration is heavily weighted toward the Department of Veterans Affairs. The top five funding entities account for 82% of awards by count and 98% by combined potential value, with the National Acquisition Center anchoring the dollar concentration at $3.2 million (a now-cancelled Blanket Purchase Agreement for Technegas products, terminated March 2025), followed by Veterans Integrated Service Network 12 at $250 thousand across a Federal Supply Schedule vehicle and related delivery orders. Veterans Integrated Service Networks 17 and 21, and the Defense Health Agency, round out active customer relationships. Cyclomedica holds two active indefinite delivery vehicles: a $225 thousand Federal Supply Schedule contract under GSA schedule FSS-61-IB (Pharmaceuticals and Drugs) awarded March 2025 by Veterans Integrated Service Network 12 through March 2030, and previously held a $3.19 million Blanket Purchase Agreement with the National Acquisition Center that was cancelled as of March 2025. Three task orders have been issued against the Pharmaceuticals and Drugs schedule ($76 thousand combined value).

Activity in the source data spans four awards in 2024, three in 2025, and four in 2026 year-to-date, with combined potential value of $3.9 million across eleven prime awards and zero subcontract work. Three awards totaling $35 thousand face ultimate completion within the next twenty-four months, presenting recompete exposure. The vendor maintains no subcontract footprint; all work is prime contracting to federal healthcare customers. Sole-source justifications appear consistently in procurement notices, citing Cyclomedica's singular expertise in Technegas diagnostic technologies as the basis for non-competitive awards.